Edition:
United Kingdom

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

34.00SEK
15 Dec 2017
Change (% chg)

-1.00kr (-2.86%)
Prev Close
35.00kr
Open
35.00kr
Day's High
35.00kr
Day's Low
33.50kr
Volume
454,734
Avg. Vol
307,151
52-wk High
44.27kr
52-wk Low
22.66kr

Summary

Name Age Since Current Position

Anders Lonner

72 2015 Executive Chairman of the Board of Directors

Peter Blom

56 2017 Chief Executive Officer

Henrik Palm

59 2015 Chief Financial Officer, Vice President

Thomas Kraft

41 Country Manager Norway

Hakan Astrom

70 2017 Director

Marianne Hamilton

70 2017 Director

Thomas Hedner

68 2014 Independent Director

Per-Anders Johansson

63 2012 Independent Director

Biographies

Name Description

Anders Lonner

Mr. Anders Lonner has been Executive Chairman of the Board of Directors of Karo Pharma AB since February 4, 2015. He has previously been Independent Chairman of the Board since May 8, 2014. He holds Master of Science in Political Science degree. He was previously Chief Executive Officer (CEO) and President for Meda AB and had before then been CEO for Astra Lakemedel with responsibility for, among other things, Astra’s Nordic subsidiaries, CEO in Karo Bio AB and President of Lakemedelsforeningen. He is Advisor for EQT. In 2014 he was nominated Honorary Doctor of Medicine at Karolinska Institutet.

Peter Blom

Mr. Peter Blom has served as Chief Executive Officer of Karo Pharma Aktiebolag since 2017. He has previously served as Country Manager Sweden at the Company. He has been employed since 2011. He completed IFL management development and various management education. He has been Managing Director Sony Sweden, Nordic Sales Director Hi3G access, COO Viasat Broadcasting, CEO of Valio Sweden, and COO Haagen Dazs Scandinavia.

Henrik Palm

Mr. Henrik Palm has been Chief Financial Officer at Karo Pharma AB since 2011. He has also been Vice President of the Company since February 4, 2015. He was previously Business Controller at Ericsson Group (1982-2000), CFO of ElektronikGruppen BK AB (publ) (2000-2009), and CFO at Feelgood Svenska AB (publ) (2009-2010). He holds a Bachelor of Business Administration degree from Goteborgs Universitet.

Thomas Kraft

Mr. Thomas Kraft serves as Country Manager Norway at Karo Pharma Aktiebolag. He has been employed since 2015. He is Civil Engineer in Technical Design from NTNU. He was Managing Director consumer products Farma Holding (2010–2015) and Sales Director of Leiv Vidar (2008-2009).

Hakan Astrom

Mr. Hakan Astrom has been Director of Karo Pharma Aktiebolag since May 11, 2017. He holds Master of Science degree in Economics and Business Administration from Handelshogskolan i Stockholm. He has been President of Kabi Pharmacia AB, CEO of Astra Pharmaceuticals Ltd., CEO of Pharmacia AB, Chairman of the Board of SOBI (Biovitrum) and Ferrosan A/S, Board Member and Vice Chairman of Karolinska Institutet. He is Chairman of the Board of PledPharma AB, Affibody AB and Board Member of Rhenman & Partners Asset Management AB and MedUniverse AB. He holds Honorary Doctorate in medicine from Sahlgrenska Akademin, Goteborgs Universitet.

Marianne Hamilton

Ms. Marianne Hamilton has been Director of Karo Pharma Aktiebolag since May 11, 2017. She holds Bachelor of Arts degree from Stockholms universitet. She has been Personnel Director and SVP at Atlas Copco AB, as well as Board Member of Meda AB, Connecta AB and Alecta. She is Board Member of KeyBroker and Lundsbergs Internatskola, as well as Member of Ersattningsakademin and Advisory Board of Stockholm Business School.

Thomas Hedner

Mr. Thomas Hedner has been Independent Member of the Board of Directors of Karo Pharma AB since May 8, 2014. He is professor in clinical pharmacology at the faculty of medicine at Gothenburg University at the department for Innovation and Entrepreneurship. He is a trained doctor (MD and Doctorate of Philosophy) and business economist (MBA). He has, as inventor and entrepreneur founded several biomedical start-ups such as Blood Pressure AB, DuoCort AB and Laccure AB. He is Chairman of the Board of Medical Manual Europe AB.

Per-Anders Johansson

Mr. Per-Anders Johansson has served as Independent Member of the Board of Directors at Karo Pharma AB since June 12, 2012. He is also Chief Executive Officer (CEO) and Chairman of CIMON AB. He also serves as Chairman of Sparbanken i Karlshamn and Board member of TC TECH SWEDEN AB. He has years of experience in technology and development. He also has long industrial experience from Karlskamn Group, Nordico and Ellos where he held leading positions. He is Mechanical Engineer with a focus on process technology.

Basic Compensation

Name Fiscal Year Total

Anders Lonner

2,899,000

Peter Blom

--

Henrik Palm

--

Thomas Kraft

--

Hakan Astrom

--

Marianne Hamilton

--

Thomas Hedner

175,000

Per-Anders Johansson

197,000
As Of  31 Dec 2016